Alpha Tau Medical (DRTS) Change in Accured Expenses (2021 - 2022)

Alpha Tau Medical's (DRTS) quarterly Change in Accured Expenses came in at -$900000.0 in Q2 2022, up 8.63% quarter-over-quarter from -$985000.0 in Q1 2022.

Alpha Tau Medical (DRTS) Change in Accured Expenses (2021 - 2022) Analysis & Trends

Alpha Tau Medical has disclosed Change in Accured Expenses across 2 years of filings, most recently posting -$900000.0 for Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 931,000.00
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 644,700.00
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 70.50 Mn
9 Abivax 95.45 Bn 95.45 Bn - -
10 Alpha Tau Medical 2,384.20 -76.42 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2022 -900,000.00
Jun 30, 2022 -900,000.00
Mar 31, 2022 -985,000.00
Mar 31, 2022 -985,000.00
Mar 31, 2021 -402,000.00
Mar 31, 2021 -402,000.00